HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme.

Abstract
Proliferating embryonic and cancer cells preferentially use aerobic glycolysis to support growth, a metabolic alteration commonly referred to as the "Warburg effect." Here, we show that the glycolytic enzyme hexokinase 2 (HK2) is crucial for the Warburg effect in human glioblastoma multiforme (GBM), the most common malignant brain tumor. In contrast to normal brain and low-grade gliomas, which express predominantly HK1, GBMs show increased HK2 expression. HK2 expression correlates with worse overall survival of GBM patients. Depletion of HK2, but neither HK1 nor pyruvate kinase M2, in GBM cells restored oxidative glucose metabolism and increased sensitivity to cell death inducers such as radiation and temozolomide. Intracranial xenografts of HK2-depleted GBM cells showed decreased proliferation and angiogenesis, but increased invasion, as well as diminished expression of hypoxia inducible factor 1α and vascular endothelial growth factor. In contrast, exogenous HK2 expression in GBM cells led to increased proliferation, therapeutic resistance, and intracranial growth. Growth was dependent on both glucose phosphorylation and mitochondrial translocation mediated by AKT signaling, which is often aberrantly activated in GBMs. Collectively, these findings suggest that therapeutic strategies to modulate the Warburg effect, such as targeting of HK2, may interfere with growth and therapeutic sensitivity of some GBMs.
AuthorsAmparo Wolf, Sameer Agnihotri, Johann Micallef, Joydeep Mukherjee, Nesrin Sabha, Rob Cairns, Cynthia Hawkins, Abhijit Guha
JournalThe Journal of experimental medicine (J Exp Med) Vol. 208 Issue 2 Pg. 313-26 (Feb 14 2011) ISSN: 1540-9538 [Electronic] United States
PMID21242296 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA Primers
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Vascular Endothelial Growth Factor A
  • Dacarbazine
  • Hexokinase
  • Temozolomide
Topics
  • Blotting, Western
  • Cell Line, Tumor
  • Cell Proliferation
  • DNA Primers (genetics)
  • Dacarbazine (analogs & derivatives)
  • Flow Cytometry
  • Fluorescent Antibody Technique
  • Glioblastoma (metabolism, physiopathology)
  • Glycolysis (physiology)
  • Hexokinase (metabolism)
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit (metabolism)
  • Immunohistochemistry
  • Neovascularization, Pathologic (metabolism)
  • Phosphorylation
  • Reverse Transcriptase Polymerase Chain Reaction
  • Temozolomide
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: